Page last updated: 2024-11-07

penicillamine and Coronary Disease

penicillamine has been researched along with Coronary Disease in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
James, DW1
Cleland, LG1
Robinson, CW1
Leonello, PP1
Sogo, N1
Campanella, C1
Webb, DJ1
Megson, IL1

Other Studies

2 other studies available for penicillamine and Coronary Disease

ArticleYear
Reversible renal failure: associated with treatment with a beta-adrenergic receptor blocking drug and non-steroidal anti-inflammatory drugs.
    The Medical journal of Australia, 1982, Mar-06, Volume: 1, Issue:5

    Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Arthritis, Rheumatoid; C

1982
S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
    British journal of pharmacology, 2000, Volume: 131, Issue:6

    Topics: Acetylcholine; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Glucosamine; Glutathione

2000